Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2022 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and CEO of Acasti,...
December 02, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

LAVAL, Québec, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced positive results for GTX-104 based on its interim...
November 24, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

LAVAL, Québec, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and CEO of Acasti...
November 12, 2021 17:34 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Announces Annual Stock Option Grants

LAVAL, Québec, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced the annual grant of stock options to its...
November 10, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022

LAVAL, Québec, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced its operating and...
November 04, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call

LAVAL, Quebec, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), today announced that it will host a conference call at 1:00 PM Eastern...
October 06, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

LAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent...
September 27, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage

LAVAL, Québec, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces the initiation of its planned pharmacokinetic...
September 22, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the Nasdaq...
September 14, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ

LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer...